Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Am J Surg. 2019 Nov;218(5):887-893. doi: 10.1016/j.amjsurg.2019.01.023. Epub 2019 Jan 25.
Significance of Glisson's capsule invasion in colorectal liver metastases (CLM) patients undergoing resection has been little investigated.
CLM patients (244) with curative resection (2011-2016) were divided into two groups: patients with (Group 1; n = 49 [20%]) and without (Group 2; n = 195 [80%]) histologically-proven Glisson invasion. Eight (16%) Group 1 patients were identified by pre- or intra-operative findings. We compared characteristics between Groups 1 and 2 and determined independent prognosticators.
Group 1 was more commonly associated with right-sided primary, CLM>5 cm, and R1 resections. Independent factors on reduced OS in entire cohort were pre-surgical chemotherapy [hazard ratio (HR): 2.68, P = 0.001], CLM>5 cm (HR: 4.39, P = 0.002), moderate or poor differentiation (HR: 2.38, P = 0.004), and R1 resection (HR: 1.92, P = 0.035).
CLM Glisson invasion was significantly associated with R1 resection. Advancements in determining Glisson invasion pre- or intra-operatively might produce benefits for CLM patients undergoing resection by reducing R1 resection.
在接受切除术的结直肠癌肝转移(CLM)患者中,Glisson 囊侵犯的意义尚未得到充分研究。
将 2011 年至 2016 年期间接受根治性切除术的 244 例 CLM 患者分为两组:有(第 1 组;n=49[20%])和无(第 2 组;n=195[80%])组织学证实的 Glisson 侵犯的患者。第 1 组中有 8 例(16%)患者通过术前或术中发现。我们比较了两组之间的特征,并确定了独立的预后因素。
第 1 组更常与右侧原发性肿瘤、CLM>5cm 和 R1 切除术相关。整个队列中降低 OS 的独立因素是术前化疗[风险比(HR):2.68,P=0.001]、CLM>5cm(HR:4.39,P=0.002)、中或低分化(HR:2.38,P=0.004)和 R1 切除术(HR:1.92,P=0.035)。
CLM 的 Glisson 侵犯与 R1 切除术显著相关。术前或术中确定 Glisson 侵犯的方法的进步可能通过减少 R1 切除术,为接受切除术的 CLM 患者带来益处。